Sarepta Plunged After Adverse Event Forces Trial Halt in the UK Post author:Sam Post published:February 11, 2018 Post category:BioPharma But the biotech swiftly indicated that it doesn’t expect the halt to last for long. Source: BioSpace You Might Also Like University of Pennsylvania Installs Second Milabs Ultra-High Resolution Preclinical Imaging System July 5, 2017 26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017 McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017
University of Pennsylvania Installs Second Milabs Ultra-High Resolution Preclinical Imaging System July 5, 2017
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017
